A Quantitative Assessment of an Alternative Anti-depression
Therapy: Pilot Study
Jacqueline Sidman*, Max D Lechtman, H Vernon Roohk and Steven J Hershey
DOI: 10.26717/BJSTR.2017.01.000255
-
Author Information
Open or Close
- The Sidman Institute, University Tower, USA
Corresponding author:
Jacqueline Sidman, The Sidman Institute, University Tower, 4199 Campus Drive, Suite 550, Irvine, California, 92612, USA
Received: July 21, 2017; Published: August 07, 2017
To view the Full Article Peer-reviewed Article PDF
Abstract
The goal of this pilot study was to evaluate psychometric testing to establish objective assessments for treating depression and co-morbid
anxiety. Clients of The Sidman Institute were asked to take the BDI-II and BAI before and after three therapy sessions. Short-Term Sidman
Hypnotherapy (STSH), independent of antidepressants, resulted in significant improvement by Wilcoxon analysis of BDI-II (Z=3.264, p=0.0011)
and BAI (Z=3.233, p=0.0013) with large effect sizes (>0.9). Rumination-associated symptoms decreased significantly, and retrospective followup
with previous clients indicated no relapse from one to three years post therapy, further indicating treatment effectiveness.
Abstract|
Introduction|
Method|
Results|
Discussion|
Authors’ Contributions|
Funding|
Acknowledgement|
References|
ISSN: 2574 -1241
